Waverley Expands UK Cancer Portfolio
Marketing Authorizations Obtained For Erlotinib Tablets
Executive Summary
Having made its entry into the UK oncology generics market late last year with capecitabine and temozolomide, Canada’s Waverley Pharma now has clearance to add erlotinib tablets to its portfolio.